palbociclib brands
9 registered brands containing palbociclib in Zimbabwe.
Palbociclib
PubChem CID 5330286Molecular formula: C24H29N7O2
Palbociclib is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor that acts by binding to the ATP pocket with an IC50 in the range of 9-15 nmol/L. It is important to consider that it presents low to absent activity against other kinases. The CDK4/6 kinase is involved, with coregulatory partner cyclin D, in the G1-S transition. Hence, inhibition of this step prevents cell cycle progression in cells in whose this pathway is functioning. This step includes the pathways of the phosphorylation of retinoblastoma protein and the E2F family of transcription factors.
Source: PubChem (NCBI) ยท compound 5330286
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| IBRANCE TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| IBRANCE TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| IBRANCE TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCICLIB PFIZER CAPSULE; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCICLIB PFIZER CAPSULE; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCICLIB PFIZER CAPSULE; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCICLIB PFIZER TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCICLIB PFIZER TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |
| PALBOCILIB PFIZER TABLET, COATED; ORAL |
Pfizer | PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) | Zimbabwe |